Prof Keertan Dheda
Professor of TB Research
United Kingdom
Keertan Dheda holds a joint appointment between the LSHTM (Professor of Mycobacteriology and Global Health) and the University of Cape Town (UCT), where is the Director of the Centre for Lung Infection and Immunity. After graduating at the University of Witwatersrand in 1992 (Certificate of Merit) he completed UK and EU-accredited training in Respiratory and General Internal Medicine in London. He graduated with a PhD from UCL in 2005 through a British Lung Foundation Fellowship award.
Affiliations
Teaching
Keertan mentors Masters, PhD, and post doctoral trainees, and teaches on specific courses at the LSHTM. From a global health perspective, he has established an international collaborative network and a research programme in which several Masters and PhD students are currently enrolled. He is currently or has previously been involved in several capacity building-related global health programmes including those with UCL, New York University (NYU), South Western Medical School (Dallas), AIIMS (New Delhi, India), SVIMS (Tirupati, India), McGill (Canada), and several African (Zimbabwe, Zambia, Tanzania, Mozambique, Botswana and Malawi) and European countries (UK, Germany, Italy, Netherlands).
Selected teaching and training activities:
i) A masters student in Infectious Diseases (Taeuk Kang) completed his research project and submitted his dissertation recently.
ii) Three LSHTM postdoctoral scientists are being trained through ongoing collaborative projects.
iii) Keertan lectured on the MSc in TB Immunology course (2 lectures).
iv) He is an advisor on the LSHTM Genomics course run by Professor Taane Clark.
v) A scientist from UCT (Dr Pooran; funded by an EU grant) will undergo training in sequencing and bio-informatics at the LSHTM.
vi) Two UCT scientists (Drs Pooran and Londt) are part of the Wellcome Human Challenge Model working group (the major UK MRC grant is held at
the LSHTM).
Research
His main research interests include the diagnosis, determinants, and outcomes of drug sensitive and drug resistant TB. He holds 6 patents related to new TB diagnostic, therapeutic or infection control technologies, one of which is currently being developed as a user-friendly test for extra-pulmonary tuberculosis. He serves in an editorial advisory capacity of several journals including Lancet Respiratory Medicine (highest ranked in Respiratory Medicine; IF= 76.2), American Journal of Respiratory and Critical Medicine (second highest ranked in Respiratory Medicine; IF= ~30), and the British Medical Journal (ranked 4th amongst general medical journals; IF= ~100), amongst others. He has been the recipient of several prestigious international awards including the International Union Against Tuberculosis and Lung Disease Scientific Award and the European Union-funded EDCTP Scientific Leadership Award. He is the founder and co-director of the charity, Free of TB, which seeks to promote the well-being of patients with TB.